SDC2 and malignant colon neoplasm: Although future studies will be required to clarify the underlying inhibitory mechanism and improve the stability of these peptides before they can be developed as new anticancer drugs, the present study lays new groundwork for the specific targeting of MMP-7 via SDC2 in colon cancer.